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Dr Thomas C. Naslund. The authors determine TEVAR for
TAD does not influence risks or death from aortic rupture since
rupture occurred earlier that TEVAR was performed. The authors
indicate TEVAR benefit may exist if done4hr post injury. Key to
justification of early treatment is the risk of early fatal aortic
rupture. Two of the 12 patients assigned to fatal rupture died
during open surgery and perhaps are more appropriately operative
deaths. The other 10 of 12 fatal ruptures died before being diag-
nosed with TAD. However, we are not provided autopsy criteria
used to establish death from aortic rupture. Some degree of
subjectivity in cause of death seems inevitable as has been the case
with other series of TAD. It remains possible some of these deaths
were from other injuries.
Early institution of medical therapy may favorably affect risks
in the 4 hr post injury and be more pragmatic than emergency
TEVAR.
The authors advocate multicenter study of TEVAR vs open
surgery but comparison with early medical therapy seems needed
too. For half a century we have performedmajor surgery to prevent
rupture and have never studied the medical option as a reasonable
alternative.
I have three questions:
1. Were autopsy criteria used to define fatal rupture?
2. Rather than early TEVAR, might early initiation of medical
therapy be a more widely available clinical recommendation?
3. What if any role does open surgery have today?
Dr Jennifer Lang (Dallas, Tex). Thank you, Dr Naslund for
your discussion and questions. Your first question asks about the
autopsy criteria we used to determine fatal rupture. Although wethickness aortic transections associated with a large hemothorax.
Most of these autopsy specimens had more than one liter of blood
in the chest or evidence in the medical record of chest tube
exsanguination.
Your second question asks whether early initiation of blood
pressure control might be an alternative to immediate TEVAR. I
think this is an excellent area for further study. Initiation of agents
to lower the heart rate and systolic blood pressuremight reduce the
risk of rupture during the early evaluation period (4 hours). This
can readily be accomplished in the trauma bay rather than delaying
treatment until the patient is transported to the ICU. However, in
the present series, 10 of the 12 patients who experienced free aortic
rupture died before the BAI was diagnosed. Therefore, we would
have missed the opportunity for early medical or surgical treatment
in these cases. This reinforces our conclusion that earlier diagnosis
is the key to improving survival in this patient population.
Your final question asks about the role for open surgery. Our
data indicate that TEVAR may not be a panacea for traumatic
aortic injuries in all patients. Specifically, we are concerned with the
notoriously poor patient follow-up in the trauma population. Our
data suggest that follow-up is equally dismal in patients with BAI.
Without routine surveillance, we cannot know the late outcome of
these patients. Furthermore, placement of TEVAR in this relatively
young population may be risky due to the known propensity for
aortic enlargement with increasing age. Use of TEVAR effectively
trades short-term benefit for potential long term risk. More studies
are needed to determine long-term outcomes. In the meantime,
careful patient selection is prudent, and open repair should be
recommended for young patients and those who are at risk for
being non-compliant with follow-up protocols.
